Results 1 to 10 of about 6,465,161 (268)

Comparison of PFS-OS between two treatment methods (surgery and then chemotherapy compared with neoadjuvant and then surgery) in patients with endometrial cancer: a retrospective study [PDF]

Majallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2023
Introduction: Endometrial cancer is one of the common diseases among women, which causes the death of many women in the world every year. The survival of patients and their response to treatment is determined based on clinical conditions and the stage of
Narjes Afrooz, Setare Nasiri, Soheila Aminimoghaddam   +2 more
doaj   +1 more source

High-dose-rate endobronchial brachytherapy in the management of advanced lung cancer - comparison according to the presence of lung atelectasis [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2021
Introduction/Objective. Locally advanced lung cancer is often accompanied by atelectasis of either a part or the entire lung. The aim of this study was to establish the benefits of brachytherapy on the patients’ quality of life, the length of the ...
Bojović Marko, Lalić Nensi, Bošković Tatjana, Ilić Miroslav, Ivanov Olivera, Ličina Jelena, Nikolin Borislava, Kalember Sandro   +7 more
doaj   +1 more source

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer

European Urology Open Science, 2023
The PROpel trial assessed the combination of olaparib + abiraterone acetate (AA) plus prednisone and androgen deprivation therapy (ADT) versus AA plus prednisone and ADT alone as first-line treatment for metastatic castration-resistant prostate cancer ...
Giuseppe Fallara, Daniele Robesti, Daniele Raggi, Francesco Montorsi, Andrea Necchi, Matthew R. Cooperberg, Bernard Malavaud, Guillaume Ploussard, Alberto Martini   +8 more
doaj   +1 more source

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2020
Objective Epithelial ovarian cancer (EOC) is rarely detected at stage 1a. Most of the patients have a good prognosis and there are limited factors that affect their survival. In the present study, we evaluated the p16 and p53 gene expressions of stage 1a
Emre Günakan, Yusuf Aytaç Tohma, Latife Atasoy Karakaş, Hüseyin Akıllı, Asuman Nihan Haberal, Ali Ayhan   +5 more
doaj   +1 more source

Evaluating the Association between Clinical Characteristics with Progression-Free Survival and 3-Year Survival in Patients with Epithelial Ovarian Cancer

Indonesian Journal of Cancer, 2021
Background: This study was conducted to determine the association between clinical characteristics, progression-free survival (PFS), and 3-year survival in patients with epithelial ovarian cancer who underwent surgery in 2016-2017 at RSUD Dr.
Brahmana Askandar Tjokroprawiro, Sonny Fadli, Budiono   +2 more
doaj   +1 more source

Efficacy and Safety Evaluation of Sintilimab for Cancer Treatment: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Frontiers in Pharmacology, 2022
Objective: Meta analysis was used to explore the efficacy and safety of Sintilimab in the treatment of cancer.Methods: The databases of CNKI, VIP, Wanfang Data, PubMed, ScienceDirect, the Cochrane Library and EMBASE were searched by computer to collect ...
Ziqi Ye, Wenchao Yang, Bixia Xuan, Xiaofang Li, Jiana He, Haiyan Si, Wenhua Ma   +6 more
doaj   +1 more source

Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort

Medicina, 2022
Background and Objectives: For stage IIIb–IV ovarian cancer, bevacizumab-containing treatment is considered the standard of care. The purpose of this study was to evaluate the efficacy of bevacizumab in combination with carboplatin and paclitaxel as a ...
Irena Conic, Bojan Nedovic, Slavica Stojnev, Ilinka Todorovska, Aleksandra Dimitrijevic, Miljan Krstic, Ivana Djordjevic, Biljana Djordjevic   +7 more
doaj   +1 more source

Outcome of Primary CNS Lymphoma; A Retrospective Analysis

Asian Pacific Journal of Cancer Care, 2022
Background: Rituximab along with high dose Methotrexate is nowadays the standard of care in treatment of PCNSL. We report the retrospective analysis of PCNSL patients who were treated with and without Rituximab at Aga Khan University Hospital, Karachi ...
Mehwish Shahzadi, Daniyaal Ahmed, Sobia Sawani, Munira Moosajee   +3 more
doaj   +1 more source

Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer

Pharmaceutics, 2022
Neutropenia is the most frequent dose-limiting toxicity reported in patients with metastatic breast cancer receiving palbociclib. The objective of this study was to investigate the pharmacokinetic–pharmacodynamic (PK/PD) relationships for toxicity (i.e.,
Perrine Courlet, Evelina Cardoso, Carole Bandiera, Athina Stravodimou, Jean-Philippe Zurcher, Haithem Chtioui, Isabella Locatelli, Laurent Arthur Decosterd, Léa Darnaud, Benoit Blanchet, Jérôme Alexandre, Anna Dorothea Wagner, Khalil Zaman, Marie Paule Schneider, Monia Guidi, Chantal Csajka   +15 more
doaj   +1 more source

Clinical Characteristics, Course, and Long-Term Outcomes in Patients with Talaromyces marneffei Infection: A 10-Year Retrospective Cohort Study

Infectious Diseases and Therapy, 2023
Introduction Talaromyces marneffei (T. marneffei), a dimorphic fungus, causes local or disseminated infection in humans. We aimed to analyze the clinical characteristics, prognostic factors, and survival outcomes of patients with T.
QingLiang Yu, Meifang Wei, Rong Xiao, Xiaona Liang, Siqiao Liang, Nan Ma, Siyao Wu, Yan Ning, Jingmin Deng, Meiling Yang, Quanfang Chen, Wen Zeng, Meihua Li, Xiaokai Feng, Zhiyi He   +14 more
doaj   +1 more source